This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by LINTON, E. A. Articles by LOWRY, P. J. Search for Related Content PubMed PubMed Citation Articles by LINTON, E. A. Articles by LOWRY, P. J.

Corticotropin-Releasing Hormone (CRH)-Binding Protein: Reduction in the Adrenocorticotropin-Releasing Activity of Placental but not Hypothalamic CRH^*

Department of Biochemistry and Physiology, University of Reading School of Animal and Microbial Sciences Whiteknights, Reading, RG6 2AJ United Kingdom

Address requests for reprints to: Dr. Elizabeth Linton, Department of Biochemistry and Physiology, University of Reading School of Animal and Microbial Sciences, Whiteknights P.O. Box 228, Reading, RG6 2AJ United Kingdom.

This study is the first to use CRH-binding protein (CRH-BP) purified from human plasma to investigate how the CRH-BP affects the physiological activity of CRH. After incubation at 37 C for 15 min, purified CRH-BP reduced the ACTH-releasing activity of synthetic human (h) CRH in a dosedependent fashion; using hCRH and CRH-BP at concentrations commonly found in late gestational maternal plasma, (1.5 and 100 ng/mL, respectively) an average 76% reduction in ACTH release was obtained. No effect was observed under the same conditions on ACTH release induced by ovine (o) CRH, which does not bind to CRH-BP. Kinetic estimations are presented to show that the extent of binding of CRH to its BP (and, hence, the reduction in its bioactivity) depends on the time available for binding and the concentration of reactants. Equilibrium between CRH and its BP at the concentrations used in the bioactivity studies take place within 400 s. Since long term secretion of placental CRH into the peripheral circulation occurs during the third trimester of pregnancy, we suggest that the presence of circulating CRH BP may partly explain how markedly elevated plasma levels of CRH coexist with normal ACTH levels at this time. We also propose that stress-induced CRH release will not be similarly quenched by the CRH-BP in the hypothalamic portal system, as the concentration of CRH released will be high, and the exposure time before reaching pituitary corticotropes will be low. Using pituitary cells constantly bathed in BP premixed with hCRH or BP alone (to mimic the situations in pregnancy and nonpregnancy, respectively), we show that short concentrated pulses of synthetic CRH (10 ng in 5 s) or rat stalk median eminence extract (one tenth stalk median eminence in 5 s) retain their ability to induce ACTH secretion despite the presence of CRH-BP. It is, thus, possible that CRH can still exert its role as a stress hormone in late gestation.

^* This work was supported by the Medical Research Council, the Wellcome Trust, and the Endowment Fund of Reading University.

Received November 13, 1989.

This article has been cited by other articles:

				P Florio, P J Lowry, C Benedetto, L Galleri, M Torricelli, A Giovannelli, R Battista, F M Reis, and F Petraglia Maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) levels in post-term pregnancy: effect of prostaglandin administration Eur. J. Endocrinol., September 1, 2007; 157(3): 279 - 284. [Abstract] [Full Text] [PDF]

				R. Smith Parturition N. Engl. J. Med., January 18, 2007; 356(3): 271 - 283. [Full Text] [PDF]

				J. Xu, J. D. Hennebold, and R. L. Stouffer Dynamic Expression and Regulation of the Corticotropin-Releasing Hormone/Urocortin-Receptor-Binding Protein System in the Primate Ovary during the Menstrual Cycle J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1544 - 1553. [Abstract] [Full Text] [PDF]

				J. R. Lindsay and L. K. Nieman The Hypothalamic-Pituitary-Adrenal Axis in Pregnancy: Challenges in Disease Detection and Treatment Endocr. Rev., October 1, 2005; 26(6): 775 - 799. [Abstract] [Full Text] [PDF]

				L. H. Allen Biological Mechanisms That Might Underlie Iron's Effects on Fetal Growth and Preterm Birth J. Nutr., February 1, 2001; 131(2): 581S - 589. [Abstract] [Full Text]

				R. J. Woods, C. F. Kemp, J. David, I. G. Sumner, and P. J. Lowry Cleavage of Recombinant Human Corticotropin-Releasing Factor (CRF)-Binding Protein Produces a 27-Kilodalton Fragment Capable of Binding CRF J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2788 - 2794. [Abstract] [Full Text]

				D. A. Giussani, J. A. Winter, S. L. Jenkins, J. D. Tame, L. M. Abrams, X.-Y. Ding, and P. W. Nathanielsz Changes in Fetal Plasma Corticotropin-Releasing Hormone during Androstenedione-Induced Labor in the Rhesus Monkey: Lack of an Effect on the Fetal Hypothalamo-Pituitary-Adrenal Axis Endocrinology, June 1, 1998; 139(6): 2803 - 2810. [Abstract] [Full Text] [PDF]

				M. Keller-Wood ACTH responses to CRF and AVP in pregnant and nonpregnant ewes Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1998; 274(6): R1762 - R1768. [Abstract] [Full Text] [PDF]

				D. N. Cortright, K. A. Goosens, J. Shonee Lesh, and A. F. Seasholtz Isolation and Characterization of the Rat Corticotropin-Releasing Hormone (CRH)-Binding Protein Gene: Transcriptional Regulation by Cyclic Adenosine Monophosphate and CRH Endocrinology, May 1, 1997; 138(5): 2098 - 2108. [Abstract] [Full Text] [PDF]